LeadScope: Software for Exploring Large Sets of Screening Data

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of chemical information and computer sciences

• Publication date

  2000-09-13

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1021/CI0000631PMID 11128088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Substructure Isomorphism Matrix

  2000cited by this paper
• A Method for Visualizing Recurrent Topological Substructures in Sets of Active Molecules

  1998cited by this paper
• Recursive Partitioning Analysis of a Large Structure-Activity Data Set Using Three-Dimensional Descriptors1

  1998cited by this paper
• Chemical Similarity Searching

  1998cited by this paper
• RECAP-Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry

  1998cited by this paper
• Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity.

  1998cited by this paper
• SLASH: a program for analysing the functional groups in molecules.

  1998cited by this paper
• 3DFS: A New 3D Flexible Searching System for Use in Drug Design

  1998cited by this paper
• Mining the NCI Anticancer Drug Discovery Databases: Genetic Function Approximation for the QSAR Study of Anticancer Ellipticine Analogues

  1998cited by this paper
• Analysis of a Large Structure‐Activity Data Set Using Recursive Partitioning

  1997cited by this paper
• Toward an Information Visualization Workspace: Combining Multiple Means of Expression

  1997cited by this paper
• Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors.

  1997cited by this paper
• The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets.

  1997cited by this paper
• QSAR and Molecular Modelling of Catamphiphilic Drugs Able to Modulate Multidrug Resistance in Tumors

  1997cited by this paper
• The properties of known drugs. 1. Molecular frameworks.

  1996cited by this paper
• Principal components describing biological activities and molecular diversity of heterocyclic aromatic ring fragments.

  1996cited by this paper
• Molecular Diversity in Chemical Databases: Comparison of Medicinal Chemistry Knowledge Bases and Databases of Commercially Available Compounds

  1996cited by this paper
• Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection

  1996cited by this paper
• Chemical Similarity Using Physiochemical Property Descriptors

  1996cited by this paper
• Stigmata: An Algorithm To Determine Structural Commonalities in Diverse Datasets

  1996cited by this paper
• Overview Oncologic, Endocrine & Metabolic: Oncologic, Endocrine & Metabolic :Ellipticine and related anticancer agents

  1996cited by this paper
• Characterising the geometric diversity of functional groups in chemical databases

  1995cited by this paper
• Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen

  1995cited by this paper
• Chemical Function Queries for 3D Database Search

  1994cited by this paper
• Neural computing in cancer drug development: predicting mechanism of action.

  1992cited by this paper
• Chemical substructure searching

  1985cited by this paper
• Atom pairs as molecular features in structure-activity studies: definition and applications

  1985cited by this paper

• Impurity Characterization Across Drug Development Stages: Analytical Methodologies and Regulatory Perspectives.

  2026cites this paper
• Novel (Q)SAR models for prediction of reversible and time-dependent inhibition of cytochrome P450 enzymes

  2025cites this paper
• In silico approaches which are used in pharmacy

  2024cites this paper
• A Method for in vitro Data and Structure Curation to Optimize for QSAR Modelling of Minimum Absolute Potency Levels and A Comparative Use Case.

  2023cites this paper
• DeepAmes: A deep learning-powered Ames test predictive model with potential for regulatory application.

  2023cites this paper
• The Nitrosamine “Saga”: Lessons Learned from Five Years of Scrutiny

  2023cites this paper
• Improving predictions and understanding of primary and ultimate biodegradation rates with machine learning models.

  2023cites this paper
• Cheminformatics and artificial intelligence for accelerating agrochemical discovery

  2023cites this paper
• In Silico Models for Predicting Acute Systemic Toxicity.

  2022cites this paper
• Novel machine learning models to predict endocrine disruption activity for high-throughput chemical screening

  2022cites this paper
• Nonclinical safety evaluation of a novel ionizable lipid for mRNA delivery.

  2022cites this paper
• The VEGAHUB Platform: The Philosophy and the Tools

  2022cites this paper
• In Silico Models for Skin Sensitization and Irritation.

  2022cites this paper
• Development of QSAR models to predict blood-brain barrier permeability

  2022cites this paper
• Implementation of in silico toxicology protocols within a visual and interactive hazard assessment platform.

  2021cites this paper
• Chem-bioinformatic approach for drug discovery

  2021cites this paper
• Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches.

  2021cites this paper
• CATMoS: Collaborative Acute Toxicity Modeling Suite

  2021cites this paper
• Development of improved QSAR models for predicting the outcome of the in vivo micronucleus genetic toxicity assay.

  2020cites this paper
• The performance, reliability and potential application of in silico models for predicting the acute oral toxicity of pharmaceutical compounds.

  2020cites this paper
• Current development of integrated web servers for preclinical safety and pharmacokinetics assessments in drug development

  2020cites this paper
• QSAR modeling of different minimum potency levels for in vitro human CAR activation and inhibition and screening of 80,086 REACH and 54,971 U.S. substances

  2020cites this paper
• Ecotoxicity Databases for QSAR Modeling

  2020cites this paper
• QSAR modeling of different minimum potency levels for in vitro human CAR activation and inhibition and screening of 80,086 REACH and 54,971 U.S. substances

  2020cites this paper
• In Silico Ecotoxicological Modeling of Pesticide Metabolites and Mixtures

  2020cites this paper
• Integrated Safety and Risk Assessment for Medical Devices and Combination Products

  2020cites this paper
• Computational approaches to identify structural alerts and their applications in environmental toxicology and drug discovery.

  2020cites this paper
• Leveraging complementary computational models for prioritizing chemicals of developmental and reproductive toxicity concern: an example of food contact materials

  2020cites this paper
• Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.

  2019cites this paper
• Concepts and Applications of Conformal Prediction in Computational Drug Discovery

  2019cites this paper
• Developing context appropriate toxicity testing approaches using new alternative methods (NAMs).

  2019cites this paper
• In silico resources to assist in the development and evaluation of physiologically-based kinetic models

  2019cites this paper
• Reaching for the bright StARs in chemical space.

  2019cites this paper
• QSAR modelling of a large imbalanced aryl hydrocarbon activation dataset by rational and random sampling and screening of 80,086 REACH pre-registered and/or registered substances

  2019cites this paper
• Structural Alerts and Random Forest Models in a Consensus Approach for Receptor Binding Molecular Initiating Events.

  2019cites this paper
• Risk Assessments for Medical Devices

  2019cites this paper
• Computational prediction models for assessing endocrine disrupting potential of chemicals

  2018cites this paper
• Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy

  2018cites this paper
• Combination of experimental and in silico methods for the assessment of the phototransformation products of the antipsychotic drug/metabolite Mesoridazine.

  2018cites this paper
• Predicting Aromatic Amine Mutagenicity with Confidence: A Case Study Using Conformal Prediction

  2018cites this paper
• Predicting Ames Mutagenicity Using Conformal Prediction in the Ames/QSAR International Challenge Project

  2018cites this paper
• QSAR models for thyroperoxidase inhibition and screening of U.S. and EU chemical inventories

  2017cites this paper
• Development and application of QSAR models for mechanisms related to endocrine disruption.

  2017cites this paper
• Chemical structure and correlation analysis of HIV-1 NNRT and NRT inhibitors and database-curated, published inhibition constants with chemical structure in diverse datasets.

  2017cites this paper
• Design and modelling in early drug development in targeting HIV-1 reverse transcriptase and Malaria

  2017cites this paper
• In Silico Tools and their Application

  2017cites this paper
• Hazard screening of photo-transformation products from pharmaceuticals: Application to selective β1-blockers atenolol and metoprolol.

  2017cites this paper
• QSAR development and profiling of 72,524 REACH substances for PXR activation and CYP3A4 induction

  2017cites this paper
• Computer assisted SOMFA Tool Validationusing 3D-QSAR Study on SelectiveInhibitors of Glucagon Receptor

  2016cites this paper
• An ensemble model of QSAR tools for regulatory risk assessment

  2016influential citation
• In Silico Methods for Predicting Drug Toxicity

  2016cites this paper
• In Silico Models for Acute Systemic Toxicity.

  2016cites this paper
• Taking Advantage of Databases.

  2016cites this paper
• ehp CERAPP : Collaborative Estrogen Receptor Activity Prediction Project

  2016cites this paper
• Initial hazard screening for genotoxicity of photo-transformation products of ciprofloxacin by applying a combination of experimental and in-silico testing.

  2016cites this paper
• Refinement, Reduction, and Replacement of Animal Toxicity Tests by Computational Methods.

  2016influential citation
• CERAPP: Collaborative Estrogen Receptor Activity Prediction Project

  2016cites this paper
• Environmental fate and effect assessment of thioridazine and its transformation products formed by photodegradation.

  2016cites this paper
• Qualitative consensus of QSAR ready biodegradability predictions

  2016cites this paper
• Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.

  2016cites this paper
• Toxicophore exploration as a screening technology for drug design and discovery: techniques, scope and limitations

  2015cites this paper
• A comparative assessment of the transformation products of S-metolachlor and its commercial product Mercantor Gold(®) and their fate in the aquatic environment by employing a combination of experimental and in silico methods.

  2015cites this paper
• Large-Scale Predictive Drug Safety: From Structural Alerts to Biological Mechanisms.

  2015cites this paper
• Fate of Pesticides in the Aquatic Environment: Determination and Identification of Dead End Degradation Products of Selected Pesticides and a Hydrological Tracer by Combination of Experimental and In Silico Methods

  2015influential citation
• New Publicly Available Chemical Query Language, CSRML, To Support Chemotype Representations for Application to Data Mining and Modeling

  2015cites this paper
• Computational methods for fragment-based ligand design: growing and linking.

  2015cites this paper
• Analysis of ToxCast Data—In Vitro and Physiochemical Properties—In the Accurate Classification of Chemicals That Induce Hepatocarcinogenesis In Vivo

  2015influential citation
• Monitoring of methotrexate chlorination in water.

  2014influential citation
• Construction and Use of Fragment-Augmented Molecular Hasse Diagrams

  2014cites this paper
• Identification of phototransformation products of thalidomide and mixture toxicity assessment: an experimental and quantitative structural activity relationships (QSAR) approach.

  2014cites this paper
• Qualitative environmental risk assessment of photolytic transformation products of iodinated X-ray contrast agent diatrizoic acid.

  2014cites this paper
• A new ICH M7 compliant expert alert system to predict the mutagenic potential of impurities Abstract

  2014cites this paper
• Assessment of hydroxylated metabolites of polychlorinated biphenyls as potential xenoestrogens: a QSAR comparative analysis∗

  2013cites this paper
• Bacterial mutagenicity screening in the pharmaceutical industry.

  2013cites this paper
• Cheminformatics based 3D-QSAR study on a series of 1,2-naphthoquinone derivatives as PTP 1B inhibitors.

  2012cites this paper
• Identification of cytochrome P450 2D6 and 2C9 substrates and inhibitors by QSAR analysis.

  2012cites this paper
• Diverse Small Molecule Inhibitors of Human Apurinic/Apyrimidinic Endonuclease APE1 Identified from a Screen of a Large Public Collection

  2012cites this paper
• 3,5-dibenzyloxy-4'-hydroxystilbene induces early caspase-9 activation during apoptosis in human K562 chronic myelogenous leukemia cells.

  2012influential citation
• Using Novel Descriptor Accounting for Ligand-Receptor Interactions To Define and Visually Explore Biologically Relevant Chemical Space

  2012cites this paper
• QSAR model for human pregnane X receptor (PXR) binding: screening of environmental chemicals and correlations with genotoxicity, endocrine disruption and teratogenicity.

  2012cites this paper
• Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics

  2011cites this paper
• Rule‐Based Classification of Chemical Structures by Scaffold

  2011cites this paper
• QSAR models for anti-androgenic effect – a preliminary study

  2011cites this paper
• SAR Monitoring of Evolving Compound Data Sets Using Activity Landscapes

  2011cites this paper
• Extracting SAR Information from a Large Collection of Anti-Malarial Screening Hits by NSG-SPT Analysis.

  2011cites this paper
• A structural feature-based computational approach for toxicology predictions

  2010cites this paper
• Similarity-Potency Trees: A Method to Search for SAR Information in Compound Data Sets and Derive SAR Rules

  2010cites this paper
• Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities.

  2010cites this paper
• Activity landscape representations for structure-activity relationship analysis.

  2010cites this paper
• Computational characterization of SAR microenvironments in high-throughput screening data

  2010cites this paper
• Compound Set Enrichment: A Novel Approach to Analysis of Primary HTS Data

  2010cites this paper
• The Advisory list for self- classification of dangerous substances

  2010cites this paper
• Inhibition of photosynthesis by a fluoroquinolone antibiotic.

  2010cites this paper
• Molecular Similarity Methods and QSAR Models As Tools for Virtual Screening

  2010cites this paper
• Classifier Design to Improve Pattern Classification and Knowledge Discovery for Imbalanced Datasets

  2009cites this paper
• Elucidation of structure-activity relationship pathways in biological screening data.

  2009cites this paper
• SMARTS Approach to Chemical Data Mining and Physicochemical Property Prediction.

  2009cites this paper
• Interactive exploration of chemical space with Scaffold Hunter.

  2009cites this paper
• QSAR models for P450 (2D6) substrate activity

  2009cites this paper
• Lead Discovery Using Virtual Screening

  2009cites this paper